Medical and Pharmaceutical Delic Labs granted permission to study psychedelics including LSD, MDMA The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds Ryan GarnerApril 15, 2022
Canada Halifax residents consumed more recreational drugs than rest of country in 2020: Statistics Canada Wastewater analysis revealed higher per-capita levels of metabolites for cannabis, cocaine and MDMA Natalia Buendia CalvilloMarch 10, 2022
Psychedelics Psilocybin safer to take with psychiatric medications than MDMA, researchers say Mixing MDMA with heavier antidepressants can be fatal Natalia Buendia CalvilloMarch 10, 2022
International Australian researchers granted $3M for psychedelic mental health treatments Two separate trials will look at MDMA for alcohol use and PTSD, as well as psilocybin-assisted therapy for anorexia nervosa Nick LabaJanuary 17, 2022
Business Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials Natalia Buendia CalvilloDecember 10, 2021
Policy Positions of NIH, FDA signal we’re ‘on the brink of a psychedelic revolution’ The psychedelic movement is no longer about anecdotes, experts say Natalia Buendia CalvilloJune 25, 2021
News California Senate passes psychedelic decriminalization bill If Bill SB-519 passes, possession of psychedelics for personal would be decriminalized, but cultivation and sale is still outlawed Natalia Buendia CalvilloJune 2, 2021
News More Canadians, Americans open to psychedelic therapy, surveys show Toronto-based Field Trip launched two new polls that show more people are open to using psychedelics to treat rising pandemic-related mental health issues Jared GnamMay 20, 2021
News FDA lifts ban on study of therapists taking MDMA After two years of dispute, MAPS is celebrating the decision Natalia Buendia CalvilloMay 14, 2021
News 67% of PTSD sufferers drop diagnosis in first MDMA Phase 3 trial Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA Natalia Buendia CalvilloMay 4, 2021